News

GEN - Genetic Engineering and Biotechnology News6h
StockWatch: Sarepta Shares Nosedive after LGMD Gene Therapy Patient Dies
The death of a third patient tied to a Sarepta Therapeutics gene therapy this year sent the company’s shares nosediving 36% Friday, halting the momentum the stock generated just a day earlier after ...
Gene Therapy Maker Sarepta Tells Fda It Won't Halt Shipments Despite Patient Deaths
Drugmaker Sarepta Therapeutics said late Friday it will not comply with a request from the Food and Drug Administration to ...
Sarepta tells FDA it won’t halt shipments despite patient deaths
In a highly unusual move, Cambridge-based Sarepta said late Friday won’t comply with a request from the Food and Drug ...
Sarepta’s Risky Gamble: Gene Therapy Stays on Market Despite FDA Request
When three patients die after taking a cutting-edge drug, most companies hit the brakes. Not Sarepta Therapeutics. The ...
MoffettNathanson Sticks to Its Buy Rating for Netflix (NFLX)
MoffettNathanson analyst Michael Nathanson maintained a Buy rating on Netflix today and set a price target of $1,400.00. The company’s shares opened today at $1,241.96. Elevate ...
Netflix (NFLX) Gets a Buy from Evercore ISI
Evercore ISI analyst Mark Mahaney maintained a Buy rating on Netflix today and set a price target of $1,375.00. The company’s shares opened today at $1,241.96. Elevate Your Inve ...